HAIC + Atezolizumab Plus Bevacizumab in Unresectable HCC
HAIC + Atezolizumab Plus Bevacizumab in Unresectable HCC
Not yet recruiting · NCT07045558 · Registry updated 2025-07-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HAIC + Atezolizumab Plus Bevacizumab in Unresectable HCC | Unresectable Hepatocellular Carcinoma | Not yet recruiting | Not stated | 2025-07-01 | NCT07045558 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| RenJi Hospital | 264 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Renji Hospital affiliated to Shanghai Jiao Tong University, School of Medicine | Shanghai | China | 1 |